-
公开(公告)号:US08211909B2
公开(公告)日:2012-07-03
申请号:US12206060
申请日:2008-09-08
Applicant: Ming-Chu Hsu , Chi-Hsin Richard King , Shu-Jen Chen , Luke Lin
Inventor: Ming-Chu Hsu , Chi-Hsin Richard King , Shu-Jen Chen , Luke Lin
IPC: A61K31/47
CPC classification number: A61K31/4709
Abstract: This invention relates to a method of treating infection by methicillin-nonsusceptibale bacteria, vancomycin-nonsusceptibale bacteria, penicillin-nonsusceptibale bacteria, clarithromycin-nonsusceptibale bacteria, or metronidazole-nonsusceptibale bacteria by administering to a subject in need thereof an effective amount of a compound of the following formula:
Abstract translation: 本发明涉及一种通过向有需要的受试者施用有效量的化合物的方法来治疗甲氧西林非感染性细菌,万古霉素 - 非感染性细菌,青霉素 - 非吸收性细菌,克拉霉素 - 非吸收性细菌或甲硝唑 - 非吸收性细菌的感染, 以下公式:
-
公开(公告)号:US20100041697A1
公开(公告)日:2010-02-18
申请号:US12495982
申请日:2009-07-01
Applicant: Kit Chiu , Luke Lin , Hao-Chen Tan , Chi-Hsin Richard King , Ming-Chu Hsu
Inventor: Kit Chiu , Luke Lin , Hao-Chen Tan , Chi-Hsin Richard King , Ming-Chu Hsu
IPC: A61K31/4709
CPC classification number: A61K9/4808 , A61K31/4709 , Y02A50/478
Abstract: This invention relates to a method of treating pneumonia by orally administering to a subject in need thereof a quinolone compound of formula (I), shown in the disclosure, at a daily dose of 2-30 mg/kg.
Abstract translation: 本发明涉及一种治疗肺炎的方法,其通过口服给予有需要的受试者本文所示的式(I)的喹诺酮化合物,日剂量为2-30mg / kg。
-
公开(公告)号:US20100004282A1
公开(公告)日:2010-01-07
申请号:US12206060
申请日:2008-09-08
Applicant: Ming-Chu Hsu , Chi-Hsin Richard King , Shu-Jen Chen , Luke Lin
Inventor: Ming-Chu Hsu , Chi-Hsin Richard King , Shu-Jen Chen , Luke Lin
IPC: A61K31/4709 , A61P31/12
CPC classification number: A61K31/4709
Abstract: This invention relates to a method of treating infection by methicillin-nonsusceptibale bacteria, vancomycin-nonsusceptibale bacteria, penicillin-nonsusceptibale bacteria, clarithromycin-nonsusceptibale bacteria, or metronidazole-nonsusceptibale bacteria by administering to a subject in need thereof an effective amount of a compound of the following formula:
Abstract translation: 本发明涉及一种通过向有需要的受试者施用有效量的化合物的方法来治疗甲氧西林非感染性细菌,万古霉素 - 非感染性细菌,青霉素 - 非吸收性细菌,克拉霉素 - 非吸收性细菌或甲硝唑 - 非吸收性细菌的感染, 以下公式:
-
-